These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1043 related items for PubMed ID: 16377675

  • 1. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P, Dromer F, Lortholary O, Dannaoui E.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [Abstract] [Full Text] [Related]

  • 2. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
    Schwarz P, Janbon G, Dromer F, Lortholary O, Dannaoui E.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):383-5. PubMed ID: 17043122
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H.
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    Serena C, Pastor FJ, Mariné M, Rodríguez MM, Guarro J.
    J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
    [Abstract] [Full Text] [Related]

  • 5. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S, Prariyachatigul C, Chaiprasert A, Rungsipanuratn W, Tanphaichitra D.
    J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [Abstract] [Full Text] [Related]

  • 7. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F, Gritsenko V, Lu H, Zhen C, Gao L, Berman J, Jiang YY.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0072321. PubMed ID: 34585947
    [Abstract] [Full Text] [Related]

  • 8. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB, Sujatha S, Parija SC.
    Indian J Pathol Microbiol; 2006 Apr 31; 49(2):307-8. PubMed ID: 16933750
    [Abstract] [Full Text] [Related]

  • 9. Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
    Shindo K.
    Drugs Exp Clin Res; 1990 Apr 31; 16(7):327-32. PubMed ID: 1965500
    [Abstract] [Full Text] [Related]

  • 10. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Barchiesi F, Schimizzi AM, Najvar LK, Bocanegra R, Caselli F, Di Cesare S, Giannini D, Di Francesco LF, Giacometti A, Carle F, Scalise G, Graybill JR.
    Antimicrob Agents Chemother; 2001 May 31; 45(5):1355-9. PubMed ID: 11302795
    [Abstract] [Full Text] [Related]

  • 11. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.
    Arechavala AI, Ochiuzzi ME, Borgnia MD, Santiso GM.
    Rev Iberoam Micol; 2009 Sep 30; 26(3):194-7. PubMed ID: 19635445
    [Abstract] [Full Text] [Related]

  • 12. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
    Barchiesi F, Spreghini E, Schimizzi AM, Maracci M, Giannini D, Carle F, Scalise G.
    Antimicrob Agents Chemother; 2004 Sep 30; 48(9):3312-6. PubMed ID: 15328090
    [Abstract] [Full Text] [Related]

  • 13. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE.
    Clin Infect Dis; 2000 Apr 30; 30(4):710-8. PubMed ID: 10770733
    [Abstract] [Full Text] [Related]

  • 14. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS, Cheong YM, Wong YH.
    Med J Malaysia; 1989 Sep 30; 44(3):194-8. PubMed ID: 2696871
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S.
    Contrib Microbiol Immunol; 1977 Sep 30; 4():147-57. PubMed ID: 342191
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R, Hollingsworth C, Qiu J, Wang A, Hughes E, Xin X, Konrath KM, Elsegeiny W, Park YD, Atakulu L, Craft JC, Tramont EC, Mannino R, Williamson PR.
    mBio; 2019 May 28; 10(3):. PubMed ID: 31138748
    [Abstract] [Full Text] [Related]

  • 17. [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
    Tanaka K, Kohno S, Maesaki S, Mitsutake K, Miyazaki H, Miyazaki T, Tomono K, Kaku M, Koga H, Hara K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 28; 31(12):1528-33. PubMed ID: 8121088
    [Abstract] [Full Text] [Related]

  • 18. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R, Izkhakov E, Siegman-Igra Y, Bash E, Polacheck I, Giladi M.
    Clin Infect Dis; 1999 Dec 28; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC, Szeszs MW, Martins MA, Baceti LB, Bonfietti LX, Purisco SU, Baez AA, Melhem MS.
    Diagn Microbiol Infect Dis; 2009 Jun 28; 64(2):146-51. PubMed ID: 19345042
    [Abstract] [Full Text] [Related]

  • 20. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN, Huang CR, Lei CB, Lee PY, Chien CC, Chang HW, Chang CS, Lu CH.
    Jpn J Infect Dis; 2004 Jun 28; 57(3):113-5. PubMed ID: 15218221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.